Materialise receives FDA clearance for diagnostic 3D printed anatomical models
Materialise (Leuven, Belgium) has become the first company in the world to receive FDA clearance for software intended for 3D printing anatomical models for diagnostic use, supporting the continued growth for personalized, point-of-care 3D printing facilities and capabilities.
Please sign in or register for FREE
Sign in to 3DMedNet
Not a member yet? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Journal of 3D Printing in Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your 3DMedNet account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>